Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 829 entries
Sorted by: Best Match Show Resources per page
How to inform: comparing written and video education interventions to increase human papillomavirus knowledge and vaccination intentions in young adults

education interventions

Lau E, Perez S.
GSID: He1Unp7Y_KYJ
A Krawczyk, E Lau, S Perez, V Delisle… - Journal of American …, 2012 - Taylor & Francis

… The present study is the first randomized-control design study comparing the efficacy of written and video HPV interventions that are guided by a theoretical framework. Both the written and video interventions facilitate consistent delivery of HPV education and...

Cite
Krawczyk, A., Lau, E., Perez, S., Delisle, V., Amsel, R., & Rosberger, Z. (2012). How to inform: comparing written and video education interventions to increase human papillomavirus knowledge and vaccination intentions in young adults. Journal of American College Health, 60(4), 316-322.
Krawczyk, Andrea, et al. "How to inform: comparing written and video education interventions to increase human papillomavirus knowledge and vaccination intentions in young adults." Journal of American College Health 60.4 (2012): 316-322.
Copy Download .nbib Format: MLA
Ready for consideration: International organizational development and change as an emerging field of practice

Science interventions

Lau CM.
GSID: FsLwnNfK8vYJ
JE Neumann, CM Lau… - The Journal of Applied …, 2009 - journals.sagepub.com

International organization1 development and change (OD&C) can be understood as an emerging field of applied behavioral and social science and of practice-based research …

Cite
Neumann, J. E., Lau, C. M., & Worley, C. G. (2009). Ready for consideration: International organizational development and change as an emerging field of practice. The Journal of Applied Behavioral Science, 45(2), 171-185.
Neumann, Jean E., Chung Ming Lau, and Christopher G. Worley. "Ready for consideration: International organizational development and change as an emerging field of practice." The Journal of Applied Behavioral Science 45.2 (2009): 171-185.
Copy Download .nbib Format: MLA
Palladium-Catalyzed Arylation of Carbasugars Enables the Discovery of Potent and Selective SGLT2 Inhibitors.

Angewandte Chemie (International ed. in English)

Ng WL, Lau KM, Lau CB, Shing TK.
PMID: 27699962
Angew Chem Int Ed Engl. 2016 Oct 24;55(44):13818-13821. doi: 10.1002/anie.201608758. Epub 2016 Oct 04.

Selective inhibition of the transporter protein sodium-glucose cotransporter 2 (SGLT2) has emerged as a promising way to control blood glucose level in diabetes patients. Reported herein is a short and convergent synthetic route towards some small-molecule SGLT2 inhibitors by...

Cite
Ng WL, Lau KM, Lau CB, et al. Palladium-Catalyzed Arylation of Carbasugars Enables the Discovery of Potent and Selective SGLT2 Inhibitors. Angew Chem Int Ed Engl. 2016;55(44):13818-13821doi: 10.1002/anie.201608758.
Ng, W. L., Lau, K. M., Lau, C. B., & Shing, T. K. (2016). Palladium-Catalyzed Arylation of Carbasugars Enables the Discovery of Potent and Selective SGLT2 Inhibitors. Angewandte Chemie (International ed. in English), 55(44), 13818-13821. https://doi.org/10.1002/anie.201608758
Ng, Wai-Lung, et al. "Palladium-Catalyzed Arylation of Carbasugars Enables the Discovery of Potent and Selective SGLT2 Inhibitors." Angewandte Chemie (International ed. in English) vol. 55,44 (2016): 13818-13821. doi: https://doi.org/10.1002/anie.201608758
Ng WL, Lau KM, Lau CB, Shing TK. Palladium-Catalyzed Arylation of Carbasugars Enables the Discovery of Potent and Selective SGLT2 Inhibitors. Angew Chem Int Ed Engl. 2016 Oct 24;55(44):13818-13821. doi: 10.1002/anie.201608758. Epub 2016 Oct 04. PMID: 27699962.
Copy Download .nbib Format: NLM
Hypercrosslinked Additives for Ageless Gas-Separation Membranes.

Angewandte Chemie (International ed. in English)

Lau CH, Mulet X, Konstas K, Doherty CM, Sani MA, Separovic F, Hill MR, Wood CD.
PMID: 26749173
Angew Chem Int Ed Engl. 2016 Feb 05;55(6):1998-2001. doi: 10.1002/anie.201508070. Epub 2016 Jan 08.

The loss of internal pores, a process known as physical aging, inhibits the long-term use of the most promising gas-separation polymers. Previously we reported that a porous aromatic framework (PAF-1) could form a remarkable nanocomposite with gas-separation polymers to...

Cite
Lau CH, Mulet X, Konstas K, et al. Hypercrosslinked Additives for Ageless Gas-Separation Membranes. Angew Chem Int Ed Engl. 2016;55(6):1998-2001doi: 10.1002/anie.201508070.
Lau, C. H., Mulet, X., Konstas, K., Doherty, C. M., Sani, M. A., Separovic, F., Hill, M. R., & Wood, C. D. (2016). Hypercrosslinked Additives for Ageless Gas-Separation Membranes. Angewandte Chemie (International ed. in English), 55(6), 1998-2001. https://doi.org/10.1002/anie.201508070
Lau, Cher Hon, et al. "Hypercrosslinked Additives for Ageless Gas-Separation Membranes." Angewandte Chemie (International ed. in English) vol. 55,6 (2016): 1998-2001. doi: https://doi.org/10.1002/anie.201508070
Lau CH, Mulet X, Konstas K, Doherty CM, Sani MA, Separovic F, Hill MR, Wood CD. Hypercrosslinked Additives for Ageless Gas-Separation Membranes. Angew Chem Int Ed Engl. 2016 Feb 05;55(6):1998-2001. doi: 10.1002/anie.201508070. Epub 2016 Jan 08. PMID: 26749173.
Copy Download .nbib Format: NLM
Quality standards for DNA sequence variation databases to improve clinical management under development in Australia.

Applied & translational genomics

Bennetts B, Caramins M, Hsu A, Lau C, Mead S, Meldrum C, Smith TD, Suthers G, Taylor GR, Cotton RG, Tyrrell V.
PMID: 27294016
Appl Transl Genom. 2014 Jul 10;3(3):54-7. doi: 10.1016/j.atg.2014.07.002. eCollection 2014 Sep 01.

Despite the routine nature of comparing sequence variations identified during clinical testing to database records, few databases meet quality requirements for clinical diagnostics. To address this issue, The Royal College of Pathologists of Australasia (RCPA) in collaboration with the...

Cite
Bennetts B, Caramins M, Hsu A, et al. Quality standards for DNA sequence variation databases to improve clinical management under development in Australia. Appl Transl Genom. 2014;3(3):54-7doi: 10.1016/j.atg.2014.07.002.
Bennetts, B., Caramins, M., Hsu, A., Lau, C., Mead, S., Meldrum, C., Smith, T. D., Suthers, G., Taylor, G. R., Cotton, R. G., & Tyrrell, V. (2014). Quality standards for DNA sequence variation databases to improve clinical management under development in Australia. Applied & translational genomics, 3(3), 54-7. https://doi.org/10.1016/j.atg.2014.07.002
Bennetts, B, et al. "Quality standards for DNA sequence variation databases to improve clinical management under development in Australia." Applied & translational genomics vol. 3,3 (2014): 54-7. doi: https://doi.org/10.1016/j.atg.2014.07.002
Bennetts B, Caramins M, Hsu A, Lau C, Mead S, Meldrum C, Smith TD, Suthers G, Taylor GR, Cotton RG, Tyrrell V. Quality standards for DNA sequence variation databases to improve clinical management under development in Australia. Appl Transl Genom. 2014 Jul 10;3(3):54-7. doi: 10.1016/j.atg.2014.07.002. eCollection 2014 Sep 01. PMID: 27294016; PMCID: PMC4888016.
Copy Download .nbib Format: NLM
Survival outcomes in severe congenital versus non-congenital pulmonary hypertension.

Heart Asia

Arnott C, Boehm C, Lau E, Celermajer DS.
PMID: 27326222
Heart Asia. 2016 Jan 19;8(1):3-7. doi: 10.1136/heartasia-2015-010702. eCollection 2016.

OBJECTIVE: Since 2006, our institution has cared for 70 patients with pulmonary arterial hypertension (PAH) and severe right ventricular (RV) hypertension; 44 with congenital heart disease (CHD) had Eisenmenger syndrome (ES) and 26 had PAH without CHD. We sought...

Cite
Arnott C, Boehm C, Lau E, et al. Survival outcomes in severe congenital versus non-congenital pulmonary hypertension. Heart Asia. 2016;8(1):3-7doi: 10.1136/heartasia-2015-010702.
Arnott, C., Boehm, C., Lau, E., & Celermajer, D. S. (2016). Survival outcomes in severe congenital versus non-congenital pulmonary hypertension. Heart Asia, 8(1), 3-7. https://doi.org/10.1136/heartasia-2015-010702
Arnott, Clare, et al. "Survival outcomes in severe congenital versus non-congenital pulmonary hypertension." Heart Asia vol. 8,1 (2016): 3-7. doi: https://doi.org/10.1136/heartasia-2015-010702
Arnott C, Boehm C, Lau E, Celermajer DS. Survival outcomes in severe congenital versus non-congenital pulmonary hypertension. Heart Asia. 2016 Jan 19;8(1):3-7. doi: 10.1136/heartasia-2015-010702. eCollection 2016. PMID: 27326222; PMCID: PMC4898627.
Copy Download .nbib Format: NLM
Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value.

Rand health quarterly

Garber S, Gates SM, Keeler EB, Vaiana ME, Mulcahy AW, Lau C, Kellermann AL.
PMID: 28083317
Rand Health Q. 2014 Mar 01;4(1):3. eCollection 2014.

New medical technologies are a leading driver of U.S. health care spending. This article identifies promising policy options to change which medical technologies are created, with two related policy goals: (1) Reduce total health care spending with the smallest...

Cite
Garber S, Gates SM, Keeler EB, et al. Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value. Rand Health Q. 2014;4(1):3
Garber, S., Gates, S. M., Keeler, E. B., Vaiana, M. E., Mulcahy, A. W., Lau, C., & Kellermann, A. L. (2014). Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value. Rand health quarterly, 4(1), 3.
Garber, Steven, et al. "Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value." Rand health quarterly vol. 4,1 (2014): 3.
Garber S, Gates SM, Keeler EB, Vaiana ME, Mulcahy AW, Lau C, Kellermann AL. Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value. Rand Health Q. 2014 Mar 01;4(1):3. eCollection 2014. PMID: 28083317; PMCID: PMC5051971.
Copy Download .nbib Format: NLM
Informed Consent of the Chronic Total Occlusion Patient.

Interventional cardiology clinics

Lau E, Whitlow P.
PMID: 28582022
Interv Cardiol Clin. 2012 Jul;1(3):365-372. doi: 10.1016/j.iccl.2012.04.005. Epub 2012 Jun 06.

This article focuses on the general principles of informed consent, then highlights the particular risks associated with chronic total occlusion interventions. The goal is to provide a basic framework for the interventional cardiologist to use when having consent discussions...

Cite
Lau E, Whitlow P. Informed Consent of the Chronic Total Occlusion Patient. Interv Cardiol Clin. 2012;1(3):365-372doi: 10.1016/j.iccl.2012.04.005.
Lau, E., & Whitlow, P. (2012). Informed Consent of the Chronic Total Occlusion Patient. Interventional cardiology clinics, 1(3), 365-372. https://doi.org/10.1016/j.iccl.2012.04.005
Lau, Evan, and Whitlow, Patrick. "Informed Consent of the Chronic Total Occlusion Patient." Interventional cardiology clinics vol. 1,3 (2012): 365-372. doi: https://doi.org/10.1016/j.iccl.2012.04.005
Lau E, Whitlow P. Informed Consent of the Chronic Total Occlusion Patient. Interv Cardiol Clin. 2012 Jul;1(3):365-372. doi: 10.1016/j.iccl.2012.04.005. Epub 2012 Jun 06. PMID: 28582022.
Copy Download .nbib Format: NLM
Getting the most out of RNA-seq data analysis.

PeerJ

Khang TF, Lau CY.
PMID: 26539333
PeerJ. 2015 Oct 29;3:e1360. doi: 10.7717/peerj.1360. eCollection 2015.

Background. A common research goal in transcriptome projects is to find genes that are differentially expressed in different phenotype classes. Biologists might wish to validate such gene candidates experimentally, or use them for downstream systems biology analysis. Producing a...

Cite
Khang TF, Lau CY. Getting the most out of RNA-seq data analysis. PeerJ. 2015;3:e1360doi: 10.7717/peerj.1360.
Khang, T. F., & Lau, C. Y. (2015). Getting the most out of RNA-seq data analysis. PeerJ, 3e1360. https://doi.org/10.7717/peerj.1360
Khang, Tsung Fei, and Lau, Ching Yee. "Getting the most out of RNA-seq data analysis." PeerJ vol. 3 (2015): e1360. doi: https://doi.org/10.7717/peerj.1360
Khang TF, Lau CY. Getting the most out of RNA-seq data analysis. PeerJ. 2015 Oct 29;3:e1360. doi: 10.7717/peerj.1360. eCollection 2015. PMID: 26539333; PMCID: PMC4631466.
Copy Download .nbib Format: NLM
Antifungal mode of action of macrocarpal C extracted from Eucalyptus globulus Labill (Lan An) towards the dermatophyte Trichophyton mentagrophytes.

Chinese medicine

Wong JH, Lau KM, Wu YO, Cheng L, Wong CW, Yew DT, Leung PC, Fung KP, Hui M, Ng TB, Lau CB.
PMID: 26594235
Chin Med. 2015 Nov 21;10:34. doi: 10.1186/s13020-015-0068-3. eCollection 2015.

BACKGROUND: The fresh leaves of Eucalyptus globulus Labill. (Lan An) have been used in Chinese medicine for many years to treat dermatomycosis. Macrocarpal C was isolated from this herb and identified as its major antifungal component by bioassay-guided purification....

Cite
Wong JH, Lau KM, Wu YO, et al. Antifungal mode of action of macrocarpal C extracted from Eucalyptus globulus Labill (Lan An) towards the dermatophyte Trichophyton mentagrophytes. Chin Med. 2015;10:34doi: 10.1186/s13020-015-0068-3.
Wong, J. H., Lau, K. M., Wu, Y. O., Cheng, L., Wong, C. W., Yew, D. T., Leung, P. C., Fung, K. P., Hui, M., Ng, T. B., & Lau, C. B. (2015). Antifungal mode of action of macrocarpal C extracted from Eucalyptus globulus Labill (Lan An) towards the dermatophyte Trichophyton mentagrophytes. Chinese medicine, 1034. https://doi.org/10.1186/s13020-015-0068-3
Wong, Jack Ho, et al. "Antifungal mode of action of macrocarpal C extracted from Eucalyptus globulus Labill (Lan An) towards the dermatophyte Trichophyton mentagrophytes." Chinese medicine vol. 10 (2015): 34. doi: https://doi.org/10.1186/s13020-015-0068-3
Wong JH, Lau KM, Wu YO, Cheng L, Wong CW, Yew DT, Leung PC, Fung KP, Hui M, Ng TB, Lau CB. Antifungal mode of action of macrocarpal C extracted from Eucalyptus globulus Labill (Lan An) towards the dermatophyte Trichophyton mentagrophytes. Chin Med. 2015 Nov 21;10:34. doi: 10.1186/s13020-015-0068-3. eCollection 2015. PMID: 26594235; PMCID: PMC4654844.
Copy Download .nbib Format: NLM
Genetic rearrangements of variable di-residue (RVD)-containing repeat arrays in a baculoviral TALEN system.

Molecular therapy. Methods & clinical development

Lau CH, Zhu H, Tay JC, Li Z, Tay FC, Chen C, Tan WK, Du S, Sia VK, Phang RZ, Tang SY, Yang C, Chi Z, Liang CC, Ning E, Wang S.
PMID: 26015987
Mol Ther Methods Clin Dev. 2014 Oct 29;1:14050. doi: 10.1038/mtm.2014.50. eCollection 2014.

Virus-derived gene transfer vectors have been successfully employed to express the transcription activator-like effector nucleases (TALENs) in mammalian cells. Since the DNA-binding domains of TALENs consist of the variable di-residue (RVD)-containing tandem repeat modules and virus genome with repeated...

Cite
Lau CH, Zhu H, Tay JC, et al. Genetic rearrangements of variable di-residue (RVD)-containing repeat arrays in a baculoviral TALEN system. Mol Ther Methods Clin Dev. 2014;1:14050doi: 10.1038/mtm.2014.50.
Lau, C. H., Zhu, H., Tay, J. C., Li, Z., Tay, F. C., Chen, C., Tan, W. K., Du, S., Sia, V. K., Phang, R. Z., Tang, S. Y., Yang, C., Chi, Z., Liang, C. C., Ning, E., & Wang, S. (2014). Genetic rearrangements of variable di-residue (RVD)-containing repeat arrays in a baculoviral TALEN system. Molecular therapy. Methods & clinical development, 114050. https://doi.org/10.1038/mtm.2014.50
Lau, Cia-Hin, et al. "Genetic rearrangements of variable di-residue (RVD)-containing repeat arrays in a baculoviral TALEN system." Molecular therapy. Methods & clinical development vol. 1 (2014): 14050. doi: https://doi.org/10.1038/mtm.2014.50
Lau CH, Zhu H, Tay JC, Li Z, Tay FC, Chen C, Tan WK, Du S, Sia VK, Phang RZ, Tang SY, Yang C, Chi Z, Liang CC, Ning E, Wang S. Genetic rearrangements of variable di-residue (RVD)-containing repeat arrays in a baculoviral TALEN system. Mol Ther Methods Clin Dev. 2014 Oct 29;1:14050. doi: 10.1038/mtm.2014.50. eCollection 2014. PMID: 26015987; PMCID: PMC4362386.
Copy Download .nbib Format: NLM
Metabolomic profiling of Burkholderia pseudomallei using UHPLC-ESI-Q-TOF-MS reveals specific biomarkers including 4-methyl-5-thiazoleethanol and unique thiamine degradation pathway.

Cell & bioscience

Lau SK, Lam CW, Curreem SO, Lee KC, Chow WN, Lau CC, Sridhar S, Wong SC, Martelli P, Hui SW, Yuen KY, Woo PC.
PMID: 26097677
Cell Biosci. 2015 Jun 02;5:26. doi: 10.1186/s13578-015-0018-x. eCollection 2015.

BACKGROUND: Burkholderia pseudomallei is an emerging pathogen that causes melioidosis, a serious and potentially fatal disease which requires prolonged antibiotics to prevent relapse. However, diagnosis of melioidosis can be difficult, especially in culture-negative cases. While metabolomics represents an uprising...

Cite
Lau SK, Lam CW, Curreem SO, et al. Metabolomic profiling of Burkholderia pseudomallei using UHPLC-ESI-Q-TOF-MS reveals specific biomarkers including 4-methyl-5-thiazoleethanol and unique thiamine degradation pathway. Cell Biosci. 2015;5:26doi: 10.1186/s13578-015-0018-x.
Lau, S. K., Lam, C. W., Curreem, S. O., Lee, K. C., Chow, W. N., Lau, C. C., Sridhar, S., Wong, S. C., Martelli, P., Hui, S. W., Yuen, K. Y., & Woo, P. C. (2015). Metabolomic profiling of Burkholderia pseudomallei using UHPLC-ESI-Q-TOF-MS reveals specific biomarkers including 4-methyl-5-thiazoleethanol and unique thiamine degradation pathway. Cell & bioscience, 526. https://doi.org/10.1186/s13578-015-0018-x
Lau, Susanna K P, et al. "Metabolomic profiling of Burkholderia pseudomallei using UHPLC-ESI-Q-TOF-MS reveals specific biomarkers including 4-methyl-5-thiazoleethanol and unique thiamine degradation pathway." Cell & bioscience vol. 5 (2015): 26. doi: https://doi.org/10.1186/s13578-015-0018-x
Lau SK, Lam CW, Curreem SO, Lee KC, Chow WN, Lau CC, Sridhar S, Wong SC, Martelli P, Hui SW, Yuen KY, Woo PC. Metabolomic profiling of Burkholderia pseudomallei using UHPLC-ESI-Q-TOF-MS reveals specific biomarkers including 4-methyl-5-thiazoleethanol and unique thiamine degradation pathway. Cell Biosci. 2015 Jun 02;5:26. doi: 10.1186/s13578-015-0018-x. eCollection 2015. PMID: 26097677; PMCID: PMC4475313.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 829 entries